At PolarityTE, our research is designed to deepen our understanding of skin’s complex regenerative cellular biology and use this understanding to develop new therapies for treatment of the most complex wounds, in patients with limited treatment options. We leverage our highly skilled in-house R&D team to rapidly move these strategies and therapies from bench to bedside, with the goal of delivering treatments to the patients that need them the most.
1
Utilizes a patient’s own viable (living and healthy) tissue, unlike other products made from allogeneic tissue (i.e., tissue from another human) or xenogeneic tissue (i.e., tissue from an animal), which carry risks of rejection.
2
Multicellular segments which engraft in the wound bed, which is especially important in the most complex wounds and austere local wound environments.
3
AHSC leverages multicellular segments that include varied cellular populations found within skin and regenerates functional tissue thereby closing wounds.
*Animal models are not necessarily predictive of clinical outcomes
